Ankaferd hemostat in the management of gastrointestinal hemorrhages

Table 1 Current data regarding the use of Ankaferd blood stopper in distinct states of gastrointestinal bleedings

Reference	Year	n	Diagnosis	Mean ABS volume (mL)
Ibis et al[20]	2008	1	Solitary rectal ulcer	10
Kurt et al[21]	2008	1	Dieulafoy lesion	12
Kurt et al[42]	2008	1	Distal cholangiocellular carcinoma	15
Tuncer et al[14]	2010	1	Fundal variceal bleeding	6
Ozaslan et al[17]	2009	1	Radiation colitis	20
Kurt et al[43]	2010	3	Rectum cancer	5, 14
		7	Gastric cancer	7, 9
Ozaslan et al[44]	2010	5	Gastric cancer	8
		1	Periampullary cancer	10
Beyazit et al[13]	2010	1	Sphincterotomy bleeding	3
Ozaslan et al[15]	2010	1	Variceal bleeding	10
Karaman et al[16]	2010	5	Colonic postpolypectomy bleeding	5-6
		2	Gastric postpolypectomy bleeding	5-6
		1	Oozing visible vessel at duodenum	5
Shorbagi et al[18]	2010	1	Radiation proctitis	20
Ozaslan et al[19]	2010	8	Radiation proctitis	20-30
Kurt et al[22]	2010	6	Gastric postpolypectomy bleeding	10
		2	Duodenal postpolypectomy bleeding	5, 9
		3	Colonic postpolypectomy bleeding	3, 17
		4	Gastric biopsy	10
		2	Dieulafoy lesion	47
		3	Radiation colitis	24
		2	GAVE	15
		1	Congestive gastropathy	10
Ozaslan et al[35]	2010	5	Peptic ulcer	2, 7
		2	Acute erosive gastropathy	5
		1	Esophageal ulcer	7
		1	Mallory-Weiss	13
Purnak et al[36]	2011	1	Peptic ulcer	20
Zulfikar et al[46]	2011	1	Esophageal cancer	6

ABS: Ankaferd blood stopper; GAVE: Gastric antral vascular ectasia.